Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia

Introduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells. A specific chromosomal abnormality, the Philadelphia chromosome (Ph), is present in 90% to 95%...

Full description

Bibliographic Details
Main Authors:	Yaghmaie M., Ghaffari S.H., Alimoghaddam K., Ghavamzadeh A., Mousavi S.A., Irvani M., Bahar B., Bibordi E., Jahani M
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2005-09-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	BCR-ABL CML Multiplex RT-PC
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/3197.pdf&manuscript_id=3197

Similar Items

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients
by: Mahmood S. Khazaal, et al.
Published: (2019-08-01)

Molecular diagnosis of bcr-abl fusion gene in CML patients using Monoplex-Two Steps- Reveres Transcriptase–Polymerase Chain
by: Maysaa A. Dhahii
Published: (2010-04-01)

Fusion gene bcr-abl: From etiopathogenesis to the management of chronic myeloid leukemia
by: Tri Agusti Sholikah
Published: (2017-04-01)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
by: Lucie Coster, et al.
Published: (2021-08-01)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
by: Erin Clapper, et al.
Published: (2020-03-01)

NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE
by: Gianfranco Catalano, et al.
Published: (2020-10-01)

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy
by: Huang X, et al.
Published: (2019-06-01)

A new aberrantly spliced BCR‐ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia
by: Nicole Naumann, et al.
Published: (2022-11-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case
by: Fen Zhou, et al.
Published: (2017-05-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
by: Michele Massimino, et al.
Published: (2018-02-01)

A Study on BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia from Western India
by: Pankaj Gadhia, et al.
Published: (2021-10-01)

PEG-Bottlebrush Stabilizer-Based Worm-like Nanocrystal Micelles with Long-Circulating and Controlled Release for Delivery of a BCR-ABL Inhibitor against Chronic Myeloid Leukemia (CML)
by: Huamin Liang, et al.
Published: (2022-08-01)

Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients
by: Emad-Aldin I. Osman, et al.
Published: (2010-01-01)

Detección molecular del gen BCR-ABL por RT-PCR en niños costarricenses con leucemia
by: Gerardo Jiménez-Arce, et al.
Published: (2008-12-01)

Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML
by: Zilin Li, et al.
Published: (2024-04-01)

A study to determine the clinical, hematological, cytogenetic, and molecular profile in CML patient in and around Eastern UP, India
by: Sandip Kumar, et al.
Published: (2019-01-01)

FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5
by: Kengo Takeda, et al.
Published: (2024-03-01)

The study of the impact of additional chromosomal aberrations and c-MYC and BCR::ABL1 genes amplification on CML patient’s characteristics: relation to haematological parameters and patient outcome
by: Hend Attia, et al.
Published: (2023-12-01)

Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells
by: Michele Massimino, et al.
Published: (2021-11-01)

Quantification of Main Bcr-abl Gene Transcripts in CML Patients Using Competitive RT-PCR
by: Ali Nazemi, et al.
Published: (2016-04-01)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
by: Michele Massimino, et al.
Published: (2021-06-01)

An analysis of multiplex-PCR in the detection of BCR-ABL transcripts in hematological disorders
by: Darío A. Sastre, et al.
Published: (2007-01-01)

<i>Sphagneticola Trilobata</i> (L.) Pruski (Asteraceae) Methanol Extract Induces Apoptosis in Leukemia Cells through Suppression of BCR/ABL
by: Hoang Thanh Chi, et al.
Published: (2021-05-01)

From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
by: Devin Wang, et al.
Published: (2024-02-01)

Quantification of main bcr-abl gene transcripts in CML patients using competitive RT-PCR
by: Ali Nazemi, et al.
Published: (2016-04-01)

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1
by: Hao Zhang, et al.
Published: (2022-03-01)

<i>ABL</i> Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
by: Shu-Huey Chen, et al.
Published: (2020-05-01)

Methylenetetrahydrofolate Reductase Gene C677T and A1298C Polymorphic Sequence Variations Influences the Susceptibility to Chronic Myeloid Leukemia in Kashmiri Population
by: Shahid M. Baba, et al.
Published: (2019-07-01)

Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients
by: Negar Nouri, et al.
Published: (2023-01-01)

بررسی شیوع فیوژن‌های ژن ABL-BCR در بیماران مبتلا به لوسمی میلوئیدی مزمن با روش Multiplex Reverse Transcription Polymerase Chain Reaction (Multiplex RT-PCR)
by: Farzad Alizadeh-Mofrad, et al.
Published: (2016-07-01)

Detection of p190BCR-ABL AND p210BCR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR
by: Aya Bonilla, Carlos Alberto, et al.
Published: (2014-10-01)

Monitoração molecular da Leucemia Mielóide Crônica na era do imatinibe Molecular monitoring of Chronic Myeloid Leukemia in the imatinib era
by: Israel Bendit
Published: (2008-04-01)

Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
by: Rachid Lahlil, et al.
Published: (2023-11-01)

CD26/DPP-4 in Chronic Myeloid Leukemia
by: Anna Sicuranza, et al.
Published: (2022-02-01)

Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
by: Mousa Vatanmakanian, et al.
Published: (2019-04-01)

Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysis
by: Sarah M. Choi, et al.
Published: (2017-01-01)

Digital PCR can provide improved BCR-ABL1 detection in chronic myeloid leukemia patients in deep molecular response and sensitivity of standard quantitative methods using EAC assays
by: Dagmar Smitalova, et al.
Published: (2021-05-01)